Multiple Companies Announce Quarterly Dividend Plans
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 24 2026
0mins
Source: NASDAQ.COM
- Concentrix Dividend Announcement: Concentrix's Board declared a quarterly dividend of $0.36 per share, payable on May 5, 2026, to shareholders of record as of April 24, 2026, demonstrating the company's commitment to shareholder returns.
- Columbus McKinnon Dividend Decision: Columbus McKinnon's Board approved a quarterly dividend of $0.07 per common share, expected to be paid on May 11, 2026, to shareholders of record as of May 1, 2026, reflecting the company's stable financial performance in intelligent motion solutions.
- Buckle Dividend Authorization: At its March 23, 2026, meeting, Buckle's Board authorized a quarterly dividend of $0.35 per share, set to be paid on April 29, 2026, to shareholders of record as of April 15, 2026, indicating robust operations in the retail market.
- Millrose Properties Dividend Declaration: Millrose Properties announced a quarterly cash dividend of approximately $126.2 million, or $0.76 per share, to be paid on April 15, 2026, to shareholders of record as of April 3, 2026, showcasing strong cash flow in the residential market.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy HRL?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on HRL
Wall Street analysts forecast HRL stock price to rise
5 Analyst Rating
3 Buy
2 Hold
0 Sell
Moderate Buy
Current: 20.890
Low
26.00
Averages
27.40
High
30.00
Current: 20.890
Low
26.00
Averages
27.40
High
30.00
About HRL
Hormel Foods Corporation is a global-branded food company. The Company develops, processes, and distributes a range of food products in a variety of markets. Its segments include Retail, Foodservice, and International. The Retail segment is primarily engaged in the processing, marketing, and sale of food products sold predominantly in the retail market. This segment also includes the Company’s MegaMex Foods, LLC joint venture. The Foodservice segment consists primarily of the processing, marketing, and sale of food products to foodservice, convenience store, and commercial customers located in the United States. The International segment processes, markets, and sells its products internationally. This segment also includes the results from the Company’s international joint ventures, international equity method investments, and international royalty arrangements. It has a global presence within several major international markets, including Australia, Brazil, Canada, China, and England.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Hormel Foods Set to Announce Q1 Earnings on May 28
- Earnings Announcement: Hormel Foods is set to release its Q1 earnings on May 28 before the market opens, with a consensus EPS estimate of $0.35, indicating stability in profitability year-over-year.
- Revenue Expectations: The anticipated revenue for Q1 is $2.96 billion, reflecting a 1.0% year-over-year decline, which suggests a cautious approach in navigating market challenges that could impact investor confidence.
- Historical Performance Review: Over the past two years, Hormel has beaten EPS estimates 63% of the time and revenue estimates 25% of the time, indicating a degree of reliability in earnings forecasts, though revenue growth remains under pressure.
- Dividend Declaration: Hormel Foods declared a dividend of $0.2925 per share, maintaining its payout despite the risks posed by high inflation, demonstrating the company's commitment to shareholders and confidence in its financial health.
See More
Wall Street Trading Week Outlook and Focus
- Salesforce Earnings Outlook: Salesforce is set to report earnings on Wednesday, with market concerns about its AI business still prevalent; analysts expect revenue of $11.05 billion and EPS of $3.12, and strong revenue growth could alleviate worries about slowing growth in its legacy business.
- Costco Membership Renewal Challenges: Costco will report earnings on Thursday, with expected revenue of $69.73 billion and EPS of $4.93; while high oil prices may pressure profit margins, its membership model and bulk selling strategy are likely to attract consumers, especially during periods of rising gas prices.
- Economic Data Focus: The personal consumption expenditures (PCE) price index will be released on Thursday, with a year-over-year increase expected at 3.8% and a core increase of 3.3%, which will influence the Federal Reserve's rate hike decisions, leaving the market uncertain about future rate changes.
- Investor Conference Season: This week marks the start of investor conference season, with Boeing, Johnson & Johnson, and others attending the Bernstein Strategic Decisions Conference, where analyst questions may reveal insights into market perceptions of company futures, making it a key event to watch.
See More
Stock Market Shows Strength Ahead of Holiday Weekend
- Market Recovery: The S&P 500 index reached a record high above 7,500 in May after recovering from March lows, indicating strong market recovery, although it remains just below that record, reflecting optimistic investor sentiment.
- Declining Cash Holdings: A Bank of America Securities survey shows professional investors' cash levels dropped from 4.3% to 3.9%, nearing the 4.0% sell signal, indicating that investors are chasing the market rally but may soon face capital shortages.
- Increased Inflation Pressure: The upcoming personal consumption expenditures price index is expected to show core PCE rising to 3.4% year-over-year in April, up from 3.2% in March, potentially increasing pressure on the Federal Reserve to raise interest rates, which could affect market sentiment.
- Economic Data Impact: Next week will see several economic data releases and earnings reports from key tech companies that could significantly impact the markets, particularly consumer commentary from Costco and Dollar Tree, which may trigger market volatility.
See More
AbbVie: A Top Pick in Uncertain Markets
- Stable Dividend Record: AbbVie has increased its dividend for 53 consecutive years since its spin-off in 2013, demonstrating business stability that attracts investors seeking safe investments in uncertain market conditions.
- Strong Sales Growth: AbbVie's two successors to Humira, Rinvoq and Skyrizi, are already generating higher sales than Humira at its peak, indicating the company's successful navigation of patent cliffs and laying a foundation for future growth.
- Relatively Undervalued Valuation: AbbVie’s forward P/E ratio of 14.7 is significantly lower than the healthcare sector's 16.8, highlighting its attractiveness among peers, especially as many other Dividend Kings are trading at higher valuations.
- Diverse Growth Drivers: AbbVie has enhanced its product portfolio through acquisitions of the antipsychotic drug Vraylar and migraine therapies Qulipta and Ubrelvy, increasing its growth potential and catering to various types of investors' needs.
See More
AbbVie: An Ideal Pick During Uncertain Times
- Stable Business Model: AbbVie has increased its dividend for 53 consecutive years since its founding in 1888, demonstrating strong business stability that attracts shareholders seeking safe investments, especially in uncertain market conditions.
- Strong Growth Prospects: AbbVie's revenue jumped 12.4% year-over-year in Q1 2026, while its competitor Hormel Foods only saw a 2% increase, showcasing its competitive edge and future growth potential in the pharmaceutical industry.
- Attractive Dividend Yield: With a dividend yield exceeding 3.2%, AbbVie significantly outperforms many other Dividend Kings, such as Walmart's 0.74%, making it more appealing to income-focused investors.
- Valuation Advantage: AbbVie's forward price-to-earnings ratio of 14.7 is below the healthcare sector's 16.8, indicating attractive investment value in the current market, particularly amid increasing economic uncertainty.
See More
Hormel Foods Declares Quarterly Dividend of $0.2925
- Quarterly Dividend Announcement: Hormel Foods has declared a quarterly dividend of $0.2925 per share, consistent with previous payouts, demonstrating the company's ongoing ability to maintain stable cash flow and bolstering investor confidence.
- Dividend Yield: The forward yield of 5.74% offers relative attractiveness in the current market environment, potentially drawing in income-seeking investors and further solidifying its market position.
- Shareholder Record Dates: The dividend will be payable on August 17, with a record date of July 13 and an ex-dividend date also on July 13, ensuring shareholders receive timely returns and enhancing trust between the company and its investors.
- Consecutive Dividend Payments: Hormel Foods has now announced a dividend of $0.2925 for three consecutive quarters, indicating the company's ability to uphold a stable dividend policy amid market challenges, reflecting its financial health and commitment to shareholders.
See More
Hormel Foods Set to Announce Q1 Earnings on May 28
- Earnings Announcement: Hormel Foods is set to release its Q1 earnings on May 28 before the market opens, with a consensus EPS estimate of $0.35, indicating stability in profitability year-over-year.
- Revenue Expectations: The anticipated revenue for Q1 is $2.96 billion, reflecting a 1.0% year-over-year decline, which suggests a cautious approach in navigating market challenges that could impact investor confidence.
- Historical Performance Review: Over the past two years, Hormel has beaten EPS estimates 63% of the time and revenue estimates 25% of the time, indicating a degree of reliability in earnings forecasts, though revenue growth remains under pressure.
- Dividend Declaration: Hormel Foods declared a dividend of $0.2925 per share, maintaining its payout despite the risks posed by high inflation, demonstrating the company's commitment to shareholders and confidence in its financial health.
See More
Wall Street Trading Week Outlook and Focus
- Salesforce Earnings Outlook: Salesforce is set to report earnings on Wednesday, with market concerns about its AI business still prevalent; analysts expect revenue of $11.05 billion and EPS of $3.12, and strong revenue growth could alleviate worries about slowing growth in its legacy business.
- Costco Membership Renewal Challenges: Costco will report earnings on Thursday, with expected revenue of $69.73 billion and EPS of $4.93; while high oil prices may pressure profit margins, its membership model and bulk selling strategy are likely to attract consumers, especially during periods of rising gas prices.
- Economic Data Focus: The personal consumption expenditures (PCE) price index will be released on Thursday, with a year-over-year increase expected at 3.8% and a core increase of 3.3%, which will influence the Federal Reserve's rate hike decisions, leaving the market uncertain about future rate changes.
- Investor Conference Season: This week marks the start of investor conference season, with Boeing, Johnson & Johnson, and others attending the Bernstein Strategic Decisions Conference, where analyst questions may reveal insights into market perceptions of company futures, making it a key event to watch.
See More
Stock Market Shows Strength Ahead of Holiday Weekend
- Market Recovery: The S&P 500 index reached a record high above 7,500 in May after recovering from March lows, indicating strong market recovery, although it remains just below that record, reflecting optimistic investor sentiment.
- Declining Cash Holdings: A Bank of America Securities survey shows professional investors' cash levels dropped from 4.3% to 3.9%, nearing the 4.0% sell signal, indicating that investors are chasing the market rally but may soon face capital shortages.
- Increased Inflation Pressure: The upcoming personal consumption expenditures price index is expected to show core PCE rising to 3.4% year-over-year in April, up from 3.2% in March, potentially increasing pressure on the Federal Reserve to raise interest rates, which could affect market sentiment.
- Economic Data Impact: Next week will see several economic data releases and earnings reports from key tech companies that could significantly impact the markets, particularly consumer commentary from Costco and Dollar Tree, which may trigger market volatility.
See More
AbbVie: A Top Pick in Uncertain Markets
- Stable Dividend Record: AbbVie has increased its dividend for 53 consecutive years since its spin-off in 2013, demonstrating business stability that attracts investors seeking safe investments in uncertain market conditions.
- Strong Sales Growth: AbbVie's two successors to Humira, Rinvoq and Skyrizi, are already generating higher sales than Humira at its peak, indicating the company's successful navigation of patent cliffs and laying a foundation for future growth.
- Relatively Undervalued Valuation: AbbVie’s forward P/E ratio of 14.7 is significantly lower than the healthcare sector's 16.8, highlighting its attractiveness among peers, especially as many other Dividend Kings are trading at higher valuations.
- Diverse Growth Drivers: AbbVie has enhanced its product portfolio through acquisitions of the antipsychotic drug Vraylar and migraine therapies Qulipta and Ubrelvy, increasing its growth potential and catering to various types of investors' needs.
See More
AbbVie: An Ideal Pick During Uncertain Times
- Stable Business Model: AbbVie has increased its dividend for 53 consecutive years since its founding in 1888, demonstrating strong business stability that attracts shareholders seeking safe investments, especially in uncertain market conditions.
- Strong Growth Prospects: AbbVie's revenue jumped 12.4% year-over-year in Q1 2026, while its competitor Hormel Foods only saw a 2% increase, showcasing its competitive edge and future growth potential in the pharmaceutical industry.
- Attractive Dividend Yield: With a dividend yield exceeding 3.2%, AbbVie significantly outperforms many other Dividend Kings, such as Walmart's 0.74%, making it more appealing to income-focused investors.
- Valuation Advantage: AbbVie's forward price-to-earnings ratio of 14.7 is below the healthcare sector's 16.8, indicating attractive investment value in the current market, particularly amid increasing economic uncertainty.
See More
Hormel Foods Declares Quarterly Dividend of $0.2925
- Quarterly Dividend Announcement: Hormel Foods has declared a quarterly dividend of $0.2925 per share, consistent with previous payouts, demonstrating the company's ongoing ability to maintain stable cash flow and bolstering investor confidence.
- Dividend Yield: The forward yield of 5.74% offers relative attractiveness in the current market environment, potentially drawing in income-seeking investors and further solidifying its market position.
- Shareholder Record Dates: The dividend will be payable on August 17, with a record date of July 13 and an ex-dividend date also on July 13, ensuring shareholders receive timely returns and enhancing trust between the company and its investors.
- Consecutive Dividend Payments: Hormel Foods has now announced a dividend of $0.2925 for three consecutive quarters, indicating the company's ability to uphold a stable dividend policy amid market challenges, reflecting its financial health and commitment to shareholders.
See More
